Inactive Instrument

Highlights CROSSJECT Euronext Paris

Equities

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

04:44pm	CROSSJECT : We are still believers	AL
Jul. 10	Markets Powered by Alternating Current

CROSSJECT : We are still believers	10:44am	AL
Crossject Gets EUR7 Million Public Funding for New Epinephrine Product	Jul. 10	MT
Crossject: public financing secured until 2026	Jul. 10	CF
Crossject: successful capital increase	Jun. 05	CF
CROSSJECT : Success of the capital increase	Jun. 05	AL
Crossject Raises EUR8 Million via Rights Offering	Jun. 05	MT
Crossject: capital increase until May 30	May. 27	CF
Crossject: praised for extended agreement on Zepizure	May. 03	CF
Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe	May. 02	CI
CROSSJECT : Patience is a virtue… hopefully	Apr. 03	AL
Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 02	CI
CROSSJECT : Invest Securities slightly reduces its target	Feb. 28	CF
CROSSJECT : Securing the financing needs	Feb. 28	AL
Crossject: share price falls after convertible bond issue	Feb. 27	CF
CROSSJECT : No news is not always good news...	Feb. 08	AL
Crossject: strategy advances, but visibility worries	Feb. 07	CF
CROSSJECT : Marketing initiative in the US	Jan. 06	AL
French Pharmaceutical Crossject Taps Syneos Health for US Commercialization of Epilepsy Rescue Treatment	Jan. 05	MT
CROSSJECT : A new distribution agreement in Northern Europe	Jan. 03	AL
Crossject: commercial agreement in Northern Europe	Dec. 22	CF

No results for this search